The relevance of chirality to the study of biological activity
- 1 January 1992
- journal article
- Published by Elsevier in Tetrahedron
- Vol. 48 (38) , 8155-8178
- https://doi.org/10.1016/s0040-4020(01)80486-5
Abstract
No abstract availableThis publication has 57 references indexed in Scilit:
- Racemic mixtures and single stereoisomers: Industrial concerns and issues in drug developmentChirality, 1991
- Excavations in drug chirality: 1. CyclothiazideChirality, 1991
- Racemization of Ibutilide in Solution: A Factor to Consider When Choosing to Develop the Racemate or a Single EnantiomerPharmaceutical Research, 1991
- Restoration of Inactivation in Mutants of Shaker Potassium Channels by a Peptide Derived from ShBScience, 1990
- Conformationally rigid analogs of aldose reductase inhibitor, tolrestat. Novel syntheses of naphthalene-fused .gamma.-, .delta.-, and .epsilon.-lactamsThe Journal of Organic Chemistry, 1990
- Chapter 34. Significance of Drug Stereochemistry in Modern Pharmaceutical Research and DevelopmentPublished by Elsevier ,1990
- Racemates versus enantiomers in drug development: Dogmatism or pragmatism?Chirality, 1990
- Considerations in the Development of Stereoisomeric Drugs: FDA ViewpointDrug Information Journal, 1989
- The FDA perspective on the development of stereoisomersChirality, 1989
- Kinetics and Mechanisms of Thioamide Rotational Isomerism: N-Thionaphthoyl-N-methyl Glycine DerivativeJournal of Pharmaceutical Sciences, 1985